Certificate of Analysis
TB-500 (TB4) — Batch KL-2614
This record documents the independent third-party testing performed on batch KL-2614 of TB-500 (TB4) (Thymosin Beta-4 Fragment) before release for laboratory research use.
Independently verified results
- HPLC purity
- 99.1%
- Identity (MS)
- Confirmed
- Endotoxin
- < 0.5 EU/mg
- Heavy metals
- Pass
- Date tested
- 2026-04-13
- Result
- Pass
Testing is performed by an independent laboratory. Results apply to the specified batch. All Klinity Labs compounds are supplied for laboratory research use only and are not for human or veterinary use.